ACP Comment Letter to CMS on Medicare Part B Most Favored Nation IFR

ACP letter to CMS commenting on the interim final rule on the Most Favored Nation Model for Medicare Part B drug payment and expressing concerns over consequences of high prescription drug costs causing financial strain on patients and the nation's health care system.

part b; medicare part b; mfn; most favored nation; drugs; prescription drugs; reference pricing; index pricing; international price index

Mon, 01/25/2021 - 11:52 AM EST

Mon, 01/25/2021 - 12:06 PM EST

4

acp_comment_letter_to_cms_on_medicare_part_b_most_favored_national_ifr_jan_2021.pdf

{"CreationDate":"2021-01-25T16:52:24+00:00","Creator":"Word","Keywords":"part b; medicare part b; mfn; most favored nation; drugs; prescription drugs; reference pricing; index pricing; international price index","ModDate":"2021-01-25T12:06:17-05:00","Producer":"Mac OS X 10.13.6 Quartz PDFContext","Title":"ACP Comment Letter to CMS on Medicare Part B Most Favored Nation IFR","Pages":4,"xmp:createdate":"2021-01-25T16:52:24Z","xmp:creatortool":"Word","xmp:modifydate":"2021-01-25T12:06:17-05:00","xmp:metadatadate":"2021-01-25T12:06:17-05:00","pdf:keywords":"part b; medicare part b; mfn; most favored nation; drugs; prescription drugs; reference pricing; index pricing; international price index","pdf:producer":"Mac OS X 10.13.6 Quartz PDFContext","dc:format":"application\/pdf","dc:title":"ACP Comment Letter to CMS on Medicare Part B Most Favored Nation IFR","dc:creator":"","dc:subject":["part b","medicare part b","mfn","most favored nation","drugs","prescription drugs","reference pricing","index pricing","international price index"],"xmpmm:documentid":"uuid:391a0ea3-e30b-4624-9ea0-515e7980ac3a","xmpmm:instanceid":"uuid:661f4fce-7407-4d66-9db7-8c64d6888735"}

2021